A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts

Novel agents to treat acute myeloid leukemia (AML) are needed with increased efficacy and specificity. We have synthesized a dual-specificity fusion toxin DTU2GMCSF composed of the catalytic and translocation domains of diphtheria toxin (DT) fused to the granulocyte-macrophage colony-stimulating fac...

Full description

Saved in:
Bibliographic Details
Main Author: Abi-Habib, Ralph J. (author)
Other Authors: Lui, Shihui (author), Bugge, Thomas (author), Leppla, Stephen H. (author), Frankel, Arthur (author)
Format: article
Published: 2004
Online Access:http://hdl.handle.net/10725/2732
http://dx.doi.org/10.1182/blood-2004-01-0339
http://www.bloodjournal.org/content/104/7/2143.full.pdf+html?sso-checked=true
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513459118407680
author Abi-Habib, Ralph J.
author2 Lui, Shihui
Bugge, Thomas
Leppla, Stephen H.
Frankel, Arthur
author2_role author
author
author
author
author_facet Abi-Habib, Ralph J.
Lui, Shihui
Bugge, Thomas
Leppla, Stephen H.
Frankel, Arthur
author_role author
dc.creator.none.fl_str_mv Abi-Habib, Ralph J.
Lui, Shihui
Bugge, Thomas
Leppla, Stephen H.
Frankel, Arthur
dc.date.none.fl_str_mv 2004
2015-11-30T08:58:39Z
2015-11-30T08:58:39Z
2015-11-30
dc.identifier.none.fl_str_mv 0006-4971
http://hdl.handle.net/10725/2732
http://dx.doi.org/10.1182/blood-2004-01-0339
Abi-Habib, R. J., Liu, S., Bugge, T. H., Leppla, S. H., & Frankel, A. E. (2004). A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts. Blood, 104(7), 2143-2148.
http://www.bloodjournal.org/content/104/7/2143.full.pdf+html?sso-checked=true
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Blood
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Novel agents to treat acute myeloid leukemia (AML) are needed with increased efficacy and specificity. We have synthesized a dual-specificity fusion toxin DTU2GMCSF composed of the catalytic and translocation domains of diphtheria toxin (DT) fused to the granulocyte-macrophage colony-stimulating factor (GM-CSF) in which the DT furin cleavage site 163RVRRSV170 is modified to a urokinase plasminogen activator (uPA) cleavage site 163GSGRSA170, termed U2. DTU2GMCSF was highly toxic to the TF1-vRaf AML cell line (proliferation inhibition assay; IC50 = 3.14 pM), and this toxicity was greatly inhibited following pretreatment with anti-uPA and anti-GM-CSF antibodies. The activity of this toxin was then tested on a larger group of 13 human AML cell lines; 5 of the 13 cell lines were sensitive to DTU2GMCSF. An additional 5 of the 13 cell lines became sensitive when exogenous pro-uPA was added. Sensitivity to DTU2GMCSF strongly correlated with the expression levels of uPA receptors (uPARs) and GM-CSF receptors (GM-CSFRs) as well as with total uPA levels. DTU2GMCSF was less toxic to normal cells expressing uPAR or GMCSFR alone, that is, human umbilical vein endothelial cells and peripheral macrophages, respectively. These results indicate that DTU2GMCSF may be a selective and potent agent for the treatment of patients with AML. (Blood. 2004;104:2143-2148)
eu_rights_str_mv openAccess
format article
id LAURepo_33c66c3f9ca8ee23ac4057d34ea256d3
identifier_str_mv 0006-4971
Abi-Habib, R. J., Liu, S., Bugge, T. H., Leppla, S. H., & Frankel, A. E. (2004). A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts. Blood, 104(7), 2143-2148.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/2732
publishDate 2004
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blastsAbi-Habib, Ralph J.Lui, ShihuiBugge, ThomasLeppla, Stephen H.Frankel, ArthurNovel agents to treat acute myeloid leukemia (AML) are needed with increased efficacy and specificity. We have synthesized a dual-specificity fusion toxin DTU2GMCSF composed of the catalytic and translocation domains of diphtheria toxin (DT) fused to the granulocyte-macrophage colony-stimulating factor (GM-CSF) in which the DT furin cleavage site 163RVRRSV170 is modified to a urokinase plasminogen activator (uPA) cleavage site 163GSGRSA170, termed U2. DTU2GMCSF was highly toxic to the TF1-vRaf AML cell line (proliferation inhibition assay; IC50 = 3.14 pM), and this toxicity was greatly inhibited following pretreatment with anti-uPA and anti-GM-CSF antibodies. The activity of this toxin was then tested on a larger group of 13 human AML cell lines; 5 of the 13 cell lines were sensitive to DTU2GMCSF. An additional 5 of the 13 cell lines became sensitive when exogenous pro-uPA was added. Sensitivity to DTU2GMCSF strongly correlated with the expression levels of uPA receptors (uPARs) and GM-CSF receptors (GM-CSFRs) as well as with total uPA levels. DTU2GMCSF was less toxic to normal cells expressing uPAR or GMCSFR alone, that is, human umbilical vein endothelial cells and peripheral macrophages, respectively. These results indicate that DTU2GMCSF may be a selective and potent agent for the treatment of patients with AML. (Blood. 2004;104:2143-2148)PublishedN/A2015-11-30T08:58:39Z2015-11-30T08:58:39Z20042015-11-30Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article0006-4971http://hdl.handle.net/10725/2732http://dx.doi.org/10.1182/blood-2004-01-0339Abi-Habib, R. J., Liu, S., Bugge, T. H., Leppla, S. H., & Frankel, A. E. (2004). A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts. Blood, 104(7), 2143-2148.http://www.bloodjournal.org/content/104/7/2143.full.pdf+html?sso-checked=trueenBloodinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/27322016-08-26T09:41:48Z
spellingShingle A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts
Abi-Habib, Ralph J.
status_str publishedVersion
title A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts
title_full A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts
title_fullStr A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts
title_full_unstemmed A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts
title_short A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts
title_sort A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts
url http://hdl.handle.net/10725/2732
http://dx.doi.org/10.1182/blood-2004-01-0339
http://www.bloodjournal.org/content/104/7/2143.full.pdf+html?sso-checked=true